BI
BVF Inc’s Repare Therapeutics RPTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.4M | Hold |
10,333,600
| – | – | 0.51% | 30 |
|
2025
Q1 | $10.2M | Hold |
10,333,600
| – | – | 0.42% | 33 |
|
2024
Q4 | $13.5M | Hold |
10,333,600
| – | – | 0.46% | 35 |
|
2024
Q3 | $35.5M | Hold |
10,333,600
| – | – | 1.04% | 28 |
|
2024
Q2 | $34.1M | Hold |
10,333,600
| – | – | 0.96% | 28 |
|
2024
Q1 | $48.7M | Hold |
10,333,600
| – | – | 1.34% | 22 |
|
2023
Q4 | $75.4M | Buy |
10,333,600
+2,041,612
| +25% | +$14.9M | 1.89% | 13 |
|
2023
Q3 | $100M | Hold |
8,291,988
| – | – | 2.7% | 8 |
|
2023
Q2 | $87.7M | Hold |
8,291,988
| – | – | 2.45% | 11 |
|
2023
Q1 | $81.6M | Hold |
8,291,988
| – | – | 2.98% | 9 |
|
2022
Q4 | $122M | Hold |
8,291,988
| – | – | 5.15% | 3 |
|
2022
Q3 | $101M | Hold |
8,291,988
| – | – | 4.15% | 5 |
|
2022
Q2 | $116M | Buy |
8,291,988
+2,433,212
| +42% | +$34M | 5.6% | 1 |
|
2022
Q1 | $83.4M | Buy |
5,858,776
+1,000,015
| +21% | +$14.2M | 3.34% | 9 |
|
2021
Q4 | $102M | Buy |
4,858,761
+1,136,363
| +31% | +$24M | 3.72% | 7 |
|
2021
Q3 | $97.7M | Hold |
3,722,398
| – | – | 3.81% | 6 |
|
2021
Q2 | $116M | Hold |
3,722,398
| – | – | 4.35% | 8 |
|
2021
Q1 | $114M | Buy |
3,722,398
+750,207
| +25% | +$23M | 4.28% | 6 |
|
2020
Q4 | $102M | Sell |
2,972,191
-92,543
| -3% | -$3.17M | 4.01% | 6 |
|
2020
Q3 | $94.3M | Buy |
3,064,734
+1,120,188
| +58% | +$34.5M | 5.14% | 3 |
|
2020
Q2 | $60.3M | Buy |
+1,944,546
| New | +$60.3M | 3.72% | 9 |
|